| Trial Identifier: | D4198C00003 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02583477 |
| Start Date: | March 2016 |
| Primary Completion Date: | July 2018 |
| Study Completion Date: | July 2018 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| English Translation |
| Country | Location |
|---|---|
| United Kingdom | Cambridge, United Kingdom, CB2 0QQ |
| United Kingdom | Glasgow, United Kingdom, G12 0YN |
| United Kingdom | London, United Kingdom, W12 0NN |
| United Kingdom | London, United Kingdom, SE1 9RY |
| United Kingdom | Manchester, United Kingdom, M20 4BX |
| United Kingdom | Wirral, United Kingdom, CH63 4JY |
| United States of America, CA | Stanford, CA, United States of America, 94305 |
| United States of America, NY | Rochester, NY, United States of America, 14642 |
| United States of America, PA | Pittsburgh, PA, United States of America, 15232 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company